Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease-Reference-Cited by-同舟云学术

Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease

Published:2016-06 Issue: Volume:252 Page:26-35
ISSN:0925-4927
Container-title:Psychiatry Research: Neuroimaging
language:en
Short-container-title:Psychiatry Research: Neuroimaging

Author:

Cover Keith S.,van Schijndel Ronald A.,Versteeg Adriaan,Leung Kelvin K.,Mulder Emma R.,Jong Remko A.,Visser Peter J.,Redolfi Alberto,Revillard Jerome,Grenier Baptiste,Manset David,Damangir Soheil,Bosco Paolo,Vrenken Hugo,van Dijk Bob W.,Frisoni Giovanni B.,Barkhof Frederik

Funder

European Community FP7 project

VU University Medical Center, Amsterdam, The Netherlands

Alzheimer's Disease Neuroimaging Initiative (ADNI)

National Institutes of Health

DOD ADNI

National Institute on Aging

National Institute of Biomedical Imaging and Bioengineering

Alzheimer's Association

Alzheimer's Drug Discovery Foundation

Araclon Biotech

BioClinica, Inc.

Biogen Idec Inc.

Bristol-Myers Squibb Company

Eisai Inc

Elan Pharmaceuticals, Inc.

Eli Lilly and Company

EuroImmun

F. Hoffmann-La Roche Ltd

Genentech, Inc.

Fujirebio

GE Healthcare

IXICO Ltd.

Janssen Alzheimer Immunotherapy Research & Development, LLC.

Johnson & Johnson Pharmaceutical Research & Development LLC.

Medpace, Inc.

Merck & Co., Inc.

Meso Scale Diagnostics, LLC.

NeuroRx Research

Neurotrack Technologies

Novartis Pharmaceuticals Corporation

Pfizer Inc.

Piramal Imaging

Servier

Synarc Inc.

Takeda Pharmaceutical Company

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Radiology, Nuclear Medicine and imaging,Neuroscience (miscellaneous)

Reference64 articles.

1. Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis;Altmann;Neurology,2009

2. Power calculations for clinical trials in Alzheimer's disease;Ard;J. Alzheimers Dis.,2011

3. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials;Barkhof;Nat. Rev. Neurol.,2009

4. Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates;Barnes;NeuroImage,2004

5. Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral;Barnes;Neurobiol. Aging,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized multi-modal MRI biomarkers predict 1-year clinical outcome in first-episode drug-naïve schizophrenia patients;Frontiers in Psychiatry;2024-09-13

2. Structural brain differences in the Alzheimer’s disease continuum: Insights into the heterogeneity from a large multi-site neuroimaging consortium;Biological Psychiatry: Cognitive Neuroscience and Neuroimaging;2024-07

3. Analyzing Brain Atrophy in Dementia Using Computer Vision;2022 10th International Conference on Reliability, Infocom Technologies and Optimization (Trends and Future Directions) (ICRITO);2022-10-13

4. Hippocampal structural alterations in early-stage psychosis: Specificity and relationship to clinical outcomes;NeuroImage: Clinical;2022

5. Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease;Journal of Alzheimer's Disease;2021-11-23